戻る Agenda
Next Generation Sequencing-Based Comprehensive Genomic Profiling: A Paradigm Shift in Clinical Practice
Session Chair(s)
Benjamin Horbach, MSC
Health Systems Strategy Leader - Personalised Healthcare
F. Hoffmann-La Roche, Switzerland
This session will introduce NGS-based Comprehensive Genomic Profiling (CGP) and the clinical relevance and implications of CGP for drug development and clinical practice in the future. Additionally, this session will explore the regulatory environments for NGS and CGP and consider the role of CGP in the context of a regulated learning healthcare ecosystem.
Speaker(s)
An Introduction to NGS and Comprehensive Genomic Profiling (CGP)
Thomas Penz, DRSC
CeMM, Austria
Deputy Head Biomedical Sequencing Facility
The Clinical Relevance and Implications of CGP for Drug Development and Clinical Practice
Benedikt Westphalen, DrMed
University of Munich - Comprehensive Cancer Center, Germany
Coordinator Molecular Oncology
The Role of CGP in the Context of a Regulated Learning Healthcare Ecosystem
Jorge Camarero, PHARMD, PHD, MSC
Spanish Agency For Medicines, Spain
CHMP Alternate